Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib. [electronic resource]
Producer: 20101215Description: 399-404 p. digitalISSN:- 1600-0609
- Adolescent
- Adult
- Aged
- Clone Cells -- pathology
- DNA Mutational Analysis
- Dasatinib
- Female
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukemia, Myeloid, Accelerated Phase -- drug therapy
- Male
- Middle Aged
- Polymerase Chain Reaction -- methods
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Pyrimidines -- therapeutic use
- RNA, Neoplasm -- genetics
- Thiazoles -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.